| |
Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
Am Heart J, 2010. 159(1): p. 110-6.
H. D. White, et al., |
| |
Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention
Am J Cardiol, 2009. 103(8): p. 1073-7.
A. Garcia-Alvarez, et al., |
| |
Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention
Am J Cardiol, 2009. 103(12): p. 1657-62.
R. Jabara, et al., |
| |
Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure
Am J Cardiol, 2009. 103(4): p. 512-4.
G. Li, et al., |
| |
Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention
Am J Cardiol, 2009. 104(12): p. 1674-7.
A. Shimony, et al., |
| |
Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure
Am J Cardiol, 2009. 104(7): p. 921-5.
A. Tamura, et al., |
| |
Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Am J Cardiol, 2009. 104(4): p. 519-24.
J. Xinwei, et al., |
| |
Prognostic implications of vascular complications following PCI
Catheter Cardiovasc Interv, 2009. 74(1): p. 64-73.
R. Applegate, et al., |
| |
Radial compression guided by mean artery pressure versus standard compression with a pneumatic device (RACOMAP)
Catheter Cardiovasc Interv, 2009. 73(4): p. 467-72.
J. M. Cubero, et al., |
| |
Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes
Catheter Cardiovasc Interv, 2009. 74(3): p. 408-15.
M. De Carlo, et al., |
| |
Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial
Catheter Cardiovasc Interv, 2009. 73(3): p. 319-25.
R. Gallo, et al., |
| |
Percutaneous coronary intervention in anticoagulated patients via radial artery access
Catheter Cardiovasc Interv, 2009. 73(1): p. 44-7.
G. Helft, et al., |
| |
Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion
Catheter Cardiovasc Interv, 2009. 73(2): p. 205-11.
T. Kawasaki, et al., |
| |
The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation
Catheter Cardiovasc Interv, 2009. 74(1): p. 58-63.
Y. S. Kim, et al., |
| |
Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function
Catheter Cardiovasc Interv, 2009. 74(1): p. 49-55.
A. S. Kini, et al., |
| |
A comparison of the transradial and the transfemoral approach in chronic total occlusion percutaneous coronary intervention
Catheter Cardiovasc Interv, 2009. 73(7): p. 883-7.
S. Rathore, et al., |
| |
Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG
Catheter Cardiovasc Interv, 2009. 74(2): p. 302-10.
P. Vranckx, et al., |
| |
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction
Circulation, 2009. 119(21): p. 2758-64.
D. A. Morrow, et al., |
| |
Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction
Eur Heart J, 2009. 30(8): p. 908-15.
M. L. Fokkema, et al., |
| |
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention
Eur Heart J, 2009. 30(3): p. 290-6.
R. Iijima, et al., |
| |
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study
Eur Heart J, 2009. 30(8): p. 900-7.
S. S. Jolly, et al., |
| |
Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon
Eur Heart J, 2009. 30(7): p. 765-72.
Y. Kawai, et al., |
| |
Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
Eur Heart J, 2009. 30(7): p. 757-64.
M. Majidi, et al., |
| |
Predictors and time-related impact of distal embolization during primary angioplasty
Eur Heart J, 2009. 30(3): p. 305-13.
M. Napodano, et al., |
| |
Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study
Eur Heart J, 2009. 30(11): p. 1348-55.
A. Tanaka, et al., |
| |
Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery
Heart, 2009. 95(19): p. 1612-8.
S. L. Hetherington, et al., |
| |
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study
Heart, 2009. 95(6): p. 476-82.
C. Pristipino, et al., |
| |
Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study
Heart, 2009. 95(23): p. 1937-43.
K. Rahimi, et al., |
| |
Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis
Heart, 2009. 95(7): p. 555-8.
H. E. Thomas, et al., |
| |
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
J Am Coll Cardiol, 2009. 54(14): p. 1293-302.
E. Nikolsky, et al., |
| |
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
J Am Coll Cardiol, 2009. 54(5): p. 477-86.
A. Prasad, et al., |
| |
Intravenous platelet blockade with cangrelor during PCI
N Engl J Med, 2009. 361(24): p. 2330-41.
D. L. Bhatt, et al., |
| |
Platelet inhibition with cangrelor in patients undergoing PCI
N Engl J Med, 2009. 361(24): p. 2318-29.
R. A. Harrington, et al., |
| |
Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy
Am Heart J, 2009. 157(1): p. 164-9.
O. F. Bertrand, et al., |
| |
Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
Am Heart J, 2009. 157(6): p. 1074-80.
A. B. Osherov, et al., |
| |
Incidence and predictors of stroke associated with percutaneous coronary intervention
Am J Cardiol, 2009. 104(3): p. 349-53.
A. Aggarwal, et al., |
| |
Comparison of effects of primary coronary angioplasty on left ventricular remodeling and heart failure in patients <70 versus > or =70 years with acute myocardial infarction
Am J Cardiol, 2009. 104(7): p. 926-31.
N. Carrabba, et al., |
| |
| |
| |
 |